IPO Trending
SPMLSME / BSEListed

Speciality Medicines Limited

Speciality Medicines Limited was incorporated in 2021 and focuses on marketing and distributing speciality pharmaceutical medicines, including expensive oral and injectable drugs used to treat serious and long-term health conditions in both Indian and international markets. The company offers many types of finished pharmaceutical products in different forms such as tablets, capsules, creams, syrups, eye drops, gels, injections, inhalers, nasal sprays, ointments, sachets, and suspensions. It operates through two main models: contract manufacturing of finished medicines for international markets and marketing and distribution of speciality medicines sourced from other manufacturers. The company has expanded globally with products registered or under registration in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia, and its distribution network covers more than 20 states in India and over 35 countries worldwide. As of March 31, 2025, one product was registered overseas and 60 products were under registration in five countries, contributing to revenue, and as of August 31, 2025, the company had 18 permanent employees working in different departments.

₹117 - ₹1242.33x sub
Listed Price124.00
Listing Gain+0.00%
TimelineBookbuilding IPO
Open20 Mar 2026
Close24 Mar 2026
Allotment25 Mar 2026
Listing30 Mar 2026

Quota Reservation Portions

QIBPortion: 21,000 shares
0.89%
HNIPortion: 10,89,000 shares
46.34%
RetailPortion: 10,90,000 shares
46.38%
Market MakerPortion: 1,50,000 shares
6.38%

Minimum Application Bracket Matrix

Retail2 lots / 2,000 shares
₹2,48,000
sHNI3 lots / 3,000 shares
₹3,72,000
bHNI9 lots / 9,000 shares
₹11,16,000

About the Company

Speciality Medicines Limited was incorporated in 2021 and focuses on marketing and distributing speciality pharmaceutical medicines, including expensive oral and injectable drugs used to treat serious and long-term health conditions in both Indian and international markets. The company offers many types of finished pharmaceutical products in different forms such as tablets, capsules, creams, syrups, eye drops, gels, injections, inhalers, nasal sprays, ointments, sachets, and suspensions. It operates through two main models: contract manufacturing of finished medicines for international markets and marketing and distribution of speciality medicines sourced from other manufacturers. The company has expanded globally with products registered or under registration in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia, and its distribution network covers more than 20 states in India and over 35 countries worldwide. As of March 31, 2025, one product was registered overseas and 60 products were under registration in five countries, contributing to revenue, and as of August 31, 2025, the company had 18 permanent employees working in different departments.

Company Promoters

Parth B GoyaniGoyani Sumit Babubhai

Registrar

Skyline Financial Services Private Limited